Day: November 19, 2024

Salon des Maires et des collectivités 2024: Software République launches the commercialization of its “U1st Vision” concept“A first in citizen-centric mobile services with a focus on health”, with first deliveries scheduled for late 2025Software République’s “U1st Vision” technology demonstrator hails a new era, moving from ‘mobility services’ to ‘services being mobile’.The “U1st Vision” modular concept vehicle, and the associated planning and monitoring tools, have been designed to help public actors and private service providers in the delivery of new proximity services.With the U1st vision, the Software République presents a first use case of this innovative service delivery platform with the “Health Pop-Up” module deploying decentralized, humanized, secured health services where and when needed.Salon des Maires et des collectivités,...

MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today confirms that Local Coverage Determination (LCD) L37531, relating to Micro-Invasive Glaucoma Surgery (MIGS), was adopted as scheduled and will be effective for services performed on or after November 17, 2024. The Company has previously reported that it believes the reimbursement limitations created by the new LCD has potential to significantly increase physician interest in and use of Iridex’s advanced laser-based treatments for glaucoma. The new LCD clarifies that treatments performed using Iridex’s laser consoles and probes are not MIGS procedures, and thus,...

HighlightsGrab sample with chalcopyrite bearing basalt returning 9.3% Cu in newly discovered zone east of Jumbo showing (Figs. 1-2) A grab sample south of the Friar Tuck (3.7 g/t Au over 0.9 m, Assessment File 012G/08/0078) showing within a 50+ cm wide outcrop of massive sulphide along Gregory River, the full extent of which is obscured by overburden, returned 6.7% Zn (Fig. 1) Additional grab and channel samples taken from quartz-carbonate veining bearing outcrops downslope from the Red Lode showing have confirmed the presence significant gold values including 15.8 g/t Au from a grab sample and 6.0 g/t Au over 0.34m in a channel sample (Figs. 1-2)VANCOUVER, British Columbia, Nov. 19, 2024 (GLOBE NEWSWIRE) — Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce results...

Mothercare plc Annual General Meeting 19 November 2024: Results Annual General Meeting At the annual general meeting held at 11.00am on 19 November 2024, the resolutions before the meeting were passed. The following proxy votes had been received by the Company in respect of the resolutions: Resolutions 11 to 13 were Special Resolutions.  Resolution Votes For % Votes Against %Total votes cast (including discretionary) % ISC Votes withheld*1 To receive the annual accounts, directors’ report, strategic report, directors’ remuneration report and auditor’s report 429,307,140 99.99 63,312 0.01 429,370,452 76.15 15,9932 To approve the directors’ remuneration report 429,227,087 99.97 134,654 0.03 429,361,741 76.15 24,7043 To re-elect Clive Whiley as a director 429,253,933 99.97 108,706 0.03 429,362,639 76.15 23,8064 To re-elect...

BELTSVILLE, Md., Nov. 19, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the presentation of preclinical data demonstrating that treatment with NC605, a novel anti-Siglec-15 (S15) antibody, resulted in enhanced generation of quality bone with better mechanical properties, in an oral presentation at the Osteogenesis Imperfecta Federation Europe virtual Investigator Meeting on November 15th, 2024. These results demonstrate that NC605 is a highly effective treatment for Osteogenesis Imperfecta (OI), also known as brittle bone disease in a well-established model of disease. OI is a rare disorder that results in high bone turnover, abnormal bone formation, bone...

CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate in the upcoming investor conferences detailed below. Piper Sandler 36th Annual Healthcare ConferenceDate: Tuesday, December 3, 2024Presentation: 2:00 PM ETWebcast Link Citi’s 2024 Global Healthcare Conference Date: Wednesday, December 4, 2024Presentation: 1:00 PM ETWebcast Link The webcasts will be available under the Investors section on the Company’s...

Ness Ziona, Israel, Nov. 19, 2024 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced that its stereoscopic 3D perception systems would likely comply with the strategic initiative of the impending Trump administration’s recent publicly stated commitment to establish a federal framework for fully self-driving vehicles and make it a top priority for the Department of Transportation. We believe that the Company’s existing 3D perception systems, leveraging a unique combination of visible-light and thermal long-wave infrared stereoscopic cameras, offer superior detection capabilities, making it well-suited for integration as the primary sensor suite in autonomous vehicles. By developing advanced vision technologies that...

MELBOURNE, Australia and SAN FRANCISCO, Nov. 19, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), has announced the appointment of Abby Macnish Niven as Alterity’s Company Secretary following her appointment as Chief Financial Officer of Alterity. Ms Macnish Niven assumes the role of Company Secretary from Mr Phillip Hains effective on 18 November 2024. The Board and Management of Alterity thank Phillip for his valuable contributions over the past several years and appreciate the foundation he helped establish. Ms Macnish Niven was appointed as CFO on 30 September 2024 and has extensive experience in private wealth management with groups including ANZ, UBS and Ord Minett. Ms Macnish Niven consults to a range of listed and unlisted companies in governance, finance and corporate...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Court’s approval allows transaction with Aditxt to proceed, subject to other closing conditions HALIFAX, Nova Scotia, Nov. 19, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, is pleased to announce receipt of the final order of the Ontario Superior Court of Justice (Commercial List) for the plan of arrangement (the “Arrangement”) pursuant to which Aditxt, Inc. (“NASDAQ:ADTX”) (“Aditxt”), through its wholly-owned subsidiary, Adivir, Inc., will acquire all of the issued and outstanding Class A common shares of the Company (the “Transaction”). As previously announced, the...

AVTL filed draft red herring prospectus with Securities and Exchange Board of India19 November 2024, Rotterdam, the Netherlands Following the publication of the press release dated 29 October 2024 and the press release dated 9 July 2024, AVTL has now filed the draft red herring prospectus with the Securities and Exchange Board of India (‘SEBI’). The formal approval process with SEBI is expected to take several months.AVTL is the largest Indian third-party owner and operator of tank storage terminals for liquified petroleum gas and liquid products in terms of storage capacity, as of June 30, 2024 (Source: CRISIL Report). AVTL owns and operates a network of tank storage terminals having an aggregate storage capacity of approximately 1.50 million cubic meters for liquid products and 70,800 metric tons of static capacity for LPG as of June...